These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9399491)

  • 1. Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis.
    Isaza DM; Restrepo M; Mosca W
    J Clin Microbiol; 1997 Dec; 35(12):3043-7. PubMed ID: 9399491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis.
    Brito ME; Mendonça MG; Gomes YM; Jardim ML; Abath FG
    Trans R Soc Trop Med Hyg; 2001; 95(2):203-6. PubMed ID: 11355562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum.
    Rolland L; Belkaid M; Seye A; Schneider P; Gentilini M
    Parasite; 1995 Mar; 2(1):13-21. PubMed ID: 9137640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.
    Kumar P; Pai K; Tripathi K; Pandey HP; Sundar S
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1119-23. PubMed ID: 12204969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia.
    Silveira FT; Blackwell JM; Ishikawa EA; Braga R; Shaw JJ; Quinnell RJ; Soong L; Kima P; McMahon-Pratt D; Black GF; Shaw MA
    Parasite Immunol; 1998 Jan; 20(1):19-26. PubMed ID: 9491414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Western blotting in the clinical follow-up of canine leishmaniasis.
    Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM
    J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
    Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
    Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic.
    Zeyrek FY; Korkmaz M; Ozbel Y
    Clin Vaccine Immunol; 2007 Nov; 14(11):1409-15. PubMed ID: 17761525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
    Velez I; Agudelo S; Hendrickx E; Puerta J; Grogl M; Modabber F; Berman J
    Ann Intern Med; 1997 Feb; 126(3):232-6. PubMed ID: 9027276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.
    Chiller TM; Samudio MA; Zoulek G
    Am J Trop Med Hyg; 1990 Dec; 43(6):650-6. PubMed ID: 2125177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.
    Brito ME; Mendonça MG; Gomes YM; Jardim ML; Abath FG
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):318-21. PubMed ID: 10702514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
    Romero GA; Guerra MV; Paes MG; Macêdo VO
    Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
    Correa-Cárdenas CA; Pérez J; Patino LH; Ramírez JD; Duque MC; Romero Y; Cantillo-Barraza O; Rodríguez O; Alvarado MT; Cruz C; Méndez C
    BMC Infect Dis; 2020 Dec; 20(1):938. PubMed ID: 33297972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.
    Machado-Pinto J; Pinto J; da Costa CA; Genaro O; Marques MJ; Modabber F; Mayrink W
    Int J Dermatol; 2002 Feb; 41(2):73-8. PubMed ID: 11982640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay using membrane antigens of Leishmania (Viannia) braziliensis.
    Skraba CM; Pedroso RB; Fiorini A; Rosado FR; Aristides SM; Lonardoni MV; Teixeira JJ; Silveira TG
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):411-7. PubMed ID: 24485589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of leishmania antigens from an American cutaneous leishmaniasis vaccine for diagnosis of visceral leishmaniasis.
    Ferreira WA; Mayrink W; dos Mares-Guia ML; Tavares CA
    Diagn Microbiol Infect Dis; 2003 Jan; 45(1):35-43. PubMed ID: 12573549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.